Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Anticoagulants; Cytokine; Luminex; Validation; Serum; Plasma; IL; interleukin; CC; CC-chemokine (beta chemokine); CXC; CXC-chemokine (alpha chemokine); XC; C-chemokine (gamma chemokine); TNF; tumor necrosis factor; IFN; interferon; LIGHT; homologous to ly
مقالات ISI مهار کننده فعال کننده پلاسمینوژن 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; AIC; Akaike Information Criterion; α-2-M; alpha-2-macroglobulin; Apo-AI; apolipoprotein A-I; Apo-AII; apolipoprotein A-II; CRP; C-reactive protein; CNF; carbon nanofibers; CNT; carbon nanotubes; CNT/F; carbon nanotu
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; ICUs; intensive care units; DIC; disseminated intravascular coagulation; SIRS; systemic inflammatory response syndrome; ROS; reactive oxygen species; APACHE II; Acute Physiology and Chronic Health Evaluation II; SOFA; Sequential Organ Dysfunction Assessme
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; ABCG5/8 knockout mice; (GÂ â/â); ABCG5/8 hetero mice; (GÂ +/â); CRP; C-reactive protein; HFD; high fat diet; HPLC; high performance liquid chromatography; MCP-1; monocyte chemoattractant protein 1; PAI-1; plasminogen activator inhibitor 1; Sitostero
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; uPA; urokinase plasminogen activator; PAI-1; plasminogen activator inhibitor 1; ctDNA; circulating tumor DNA; CTC; circulating tumor cells; PFS; progression-free survival; pCR; pathological complete response; SNVs; single nucleotide variants; CNVs; copy n
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AIS; Abbreviated Injury Scale; ALI; Acute Lung Injury; Ang-2; Angiopoietin-2; ARDS; Acute Respiratory Distress Syndrome; AUC; Area under the curve; BAL-F; Broncheoalveolar lavage fluid; BNP; Brain Natriuretic Peptide; CC16; Club Cell protein 16; DAMP; Dam
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Endothelium; Furin; Plasminogen activator inhibitor 1; Radiation; Vitronectin;
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Palm tocotrienols; Palm carotenes; Vascular function; Flow-mediated dilation; AI; augmentation index; BMI; body mass index; CTAB; citrate, theophylline, adenosine and dipyridamole; CV; coefficient of variance; CVD; cardiovascular disease; EFSA; European F
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Plasminogen activator inhibitor 1; Tissue plasminogen activator; Myocardial infarction; Cardiovascular diseases;
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Aging; Plasminogen activator inhibitor 1; Idiopathic pulmonary fibrosis; Fibroblast apoptosis
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; adipose-derived stem cells; ASCs; atomic force microscopy; AFM; basic fibroblast growth factors; bFGFs; body mass index; BMI; bone morphogenetic protein; BMP; brown adipose tissue; BAT; CCAAT/enhancer-binding protein; C/EBP; cyclic adenosine monophosphate
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; ADAMTS-13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CV; coefficient of variation; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; EMSI; Examination Management Services, Inc.; ERL;
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Alzheimer's disease; Mild cognitive impairment; Plasminogen activator inhibitor 1; Diagnostic marker;
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; A1AG1; α-1-acid glycoprotein; A2M; α-2-macroglobulin; A1AT; α-1-antitrypsin; ApoA-I; Apolipoprotein A-I; APOH; β-2-glycoprotein; CERU; ceruloplasmin; CD5L; CD5 antigen-like precursor; CFAB; complement factor B; CFAH; complement factor H; COPD; chronic
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Black cohosh; Plasminogen activator inhibitor 1; Vascular smooth muscle;
A novel solution phase PAI-1/uPA-biotin complex assay for the measurement of active PAI-1 in plasma
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; PAI-1; Plasminogen Activator Inhibitor 1; uPA; urokinase-type plasminogen activator; mAb; Monoclonal Antibody; pAb; Polyclonal Antibody; PE; Streptavidin-R-Phycoerythrin;
Can the choice of diet undermine the potential genetic risk of AT1R 1166A>C gene polymorphism?
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AT1R; angiotensin II type 1 receptor; MetS; metabolic syndrome; NCDs; noncommunicable diseases; T2DM; type 2 diabetes mellitus; RAS; renin angiotensin system; Ang II; angiotensin II; 3â²UTR; three prime untranslated region; WC; waist circumference; BMI;
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AHA; American Heart Association; AEPCOS; Androgen Excess PCOS Society; apoB; apolipoprotein B; apoA-I; apolipoprotein A-I; CAD; coronary artery disease; CHD; coronary heart disease; CI; confidence interval; CIMT; carotid artery intima-media thickness; CRP
Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Acaudina molpadioides; Fucoidan; Renal fibrosis; Kidney protection; Transforming growth factor-β1; Am-FUC; fucoidan from Acaudina molpadioides; CAT; catalase; DKD; diabetic kidney disease; ECM; extracellular matrix; GBM; glomerular basement membrane; GPX
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; TMPRSS2; Influenza virus; Coronavirus; Therapeutics; ARE; androgen receptor element; AEBSF; 4-(2-Aminomethyl)benzenesulfonyl fluoride hydrochloride; BHH; Bromhexine hydrochloride; CoV; coronavirus; DESC1; serine protease DESC1; EST; (2S,3S)-trans-Epoxysuc
PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; PAI-1; plasminogen activator inhibitor 1; uPA; urokinase plasminogen activator; KO; knockout; EMT; epithelial-to-mesenchymal transition; PPI; proton pump inhibitor; H. pylori; Helicobacter pylori; ECL; enterochromaffin-like; HK; H+K+-ATPase beta subunit;
TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Eosinophil; esophagitis; SerpinE1; remodeling; fibrosis; TGF-β1; BZH; Basal zone hyperplasia; EoE; Eosinophilic esophagitis; LP; Lamina propria; LRP1; Lipoprotein receptor-related protein 1; MMP; Matrix metalloproteinases; PAI-1; Plasminogen activator
Hantavirus infection-induced thrombocytopenia triggers increased production but associates with impaired aggregation of platelets except for collagen
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; HCPS; hantavirus cardiopulmonary syndrome; PUUV; Puumala virus; NE; nephropathia epidemica; AKI; acute kidney injury; ADAMTS13; a thrombospondin type 1 domain 13; PAI-1; plasminogen activator inhibitor 1; HTNV; Hantaan virus; MPV; mean platelet volume; IP
Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AAC; abdominal aortic constriction; Ang II; angiotensin II; CCK-8; Cell Counting Kit-8; CF; cardiac fibroblast; DAPI; 4â²,6-diamidino-2-phenylindol; ECM; extracellular matrix; EGFP; enhanced green fluorescent protein; EMSA; electrophoretic mobility shift
TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Kidney fibrosis; Smad proteins; TGF-β1; Bone morphogenetic proteins; Inhibitors; micro-RNAs; ALK1-6; activin receptor-like kinase 1-6; BAMBI; BMP and activin receptor membrane bound inhibitor; BMP; bone morphogenetic protein; CKD; chronic kidney disease;
The glucagon-like peptide 1 receptor agonist enhances intrinsic peroxisome proliferator-activated receptor γ activity in endothelial cells
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; GLP-1; glucagon-like peptide-1; HUVECs; human umbilical vein endothelial cells; PKA; protein kinase A; IRS-1; insulin receptor substrate-1; JNK; c-Jun N-terminal kinase; NF-κB; nuclear factor-kappa B; TNFα; tumor necrosis factor α; ICAM-1; intercellula
Multipotent mesenchymal stromal cells decrease transforming growth factor β1 expression in microglia/macrophages and down-regulate plasminogen activator inhibitor 1 expression in astrocytes after stroke
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Multipotent mesenchymal stromal cells; Microglia/macrophages; Astrocytes: transforming growth factor β1; Plasminogen activator inhibitor 1; Stroke;
Genetics of chronic rhinosinusitis: State of the field and directions forward
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Genetics; genome; variation; chronic rhinosinusitis; nasal polyposis; single nucleotide polymorphism; polymorphism; candidate gene; linkage; genome wide association study; susceptibility; sinusitis; AERD; Aspirin-exacerbated respiratory disease; AF; Allel
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; RAAS; renin-angiotensin-aldosterone system; AngII; angiotensin II; BMI; body-mass index; 25(OH)D; 25-hydroxyvitamin D; 1,25(OH)2D; 1,25-dihydroxyvitamin D; PTH; parathyroid hormone; PAI-1; plasminogen activator inhibitor 1; IL-6; interleukin 6; HOMA-I
Regular ArticleReduced clot-stability during the first 6Â hours after aneurysmal subarachnoid haemorrhage - a prospective case-control study
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; AUC; area under the clot lysis curve; CT; computed tomography; ELISA; enzyme-linked immunosorbent assays; MRI; magnetic resonance imaging; PAI-1; plasminogen activator inhibitor 1; PAP; plasmin-antiplasmin; SAH; subarachnoid haemorrhage; t-PA; tissue plas
Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Plasminogen activator inhibitor 1; Visceral obesity; Bariatric surgery; Weight loss; Fibrinolysis
Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Acupuncture; exercise; hemostatic factor; insulin resistance; adipocyte size; plasminogen activator inhibitor 1
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; BMI; body mass index; CRP; C-reactive protein; CVD; cardiovascular disease; FFM; fat-free mass; GIR; glucose infusion rate; HbA1c; glycosylated hemoglobin; HDL-C; high-density lipoprotein cholesterol; IL-6; interleukin 6; PAI-1; plasminogen activator inhi
Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Plasminogen activator inhibitor 1; Gene polymorphism; Posttransplant diabetes mellitus; Kidney transplantation
Leptin and resistin induce increased procoagulability in diabetes mellitus
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; DM; diabetes mellitus; DMSO; dimethyl sulfoxide; FVIIa; factor VIIa; FX; factor X; HUVECs; human umbilical endothelial cells; PAI; plasminogen activator inhibitor 1; SD; standard deviation; SEM; standard error of the mean; TF; tissue factor; TFPI; tissue
Cloning of the 5â² regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1)
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Ang II; Angiotensin II; AP1; Activator Protein 1; AP4; Activator Protein 4; BME; Bovine Mammary Epithelium; C/EBPb; CCAAT/Enhancer Binding Protein beta; CRE-BP; cAMP Response Element Binding Protein; DEX; Dexamethasone; ECM; Extracellular Matrix; EGF; Epi
Long-term stability of fibrinolytic factors stored at -80 °C
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; tPA; tissue plasminogen activator; PAI-1; plasminogen activator inhibitor 1; NSHDS; Northern Sweden Health and Disease Study; VIP; Västerbotten Intervention Programme; WHO-MONICA; World Health Organisation- Monitoring Trends and Determinants in Cardiovas
Activation of human mast cells through the platelet-activating factor receptor
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Anaphylaxis; histamine; human lung mast cells; human peripheral blood-derived mast cells; human skin mast cells; platelet-activating factor receptor; GAPDH; Glyceraldehyde-3-phosphate dehydrogenase; GPCR; G protein-coupled receptor; IMDM; Iscove modif
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Plasminogen activator inhibitor 1; TP53 codon 72 polymorphism; Ageing
Human Tumour Necrosis Factor: Physiological and Pathological Roles in Placenta and Endometrium
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Placenta; Trophoblast; Endometrium; TNF; ASK-1; apoptosis-signalling kinase-1; AP-1; activator protein-1; bFGF; basic fibroblast growth factor; cIAP; cellular inhibitor of apoptosis protein; COX-2; cyclooxygenase-2; CRH; cortisol releasing hormone; ECM; e
Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Fibrinolysis; Plasminogen activator inhibitor 1; Platelets; mRNA; Polymorphism;
Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 − 675 4G/5G polymorphism in angiographied coronary patients
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Coronary atherosclerosis; Genetic polymorphism; Plasminogen activator inhibitor 1; Prospective study; Type 2 diabetes
Expression of TNF-α protein in omental and subcutaneous adipose tissue in obesity
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Tumor necrosis factor-alpha; Obesity; Plasminogen activator inhibitor 1; Omentum; Vascular diseases
Correlation between omental TNF-α protein and plasma PAI-1 in obesity subjects
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Tumor necrosis factor-alpha; Obesity; Plasminogen activator inhibitor 1; Omentum; Vascular diseases
Redirection of the reaction between activated protein C and a serpin to the substrate pathway
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; α1AT; α1-antitrypsin; APC; activated protein C; DIC; disseminated intravascular coagulation; mAb; monoclonal antibody; NBD; N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-3-diazole; NBD P9 PAI-1; Ser338Cys (position P9 of RCL) mutant variant
Binding of upstream stimulatory factor 1 to the E-Box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Plasminogen activator inhibitor 1; 4G/5G polymorphism; transcription; human mast cells; upstream stimulatory factor 1; E-box; bHLH; Basic helix-loop-helix; DN; Dominant-negative; E-4G/5G; E-box adjacent to the 4G/5G allele; EMSA; Electrophoretic mobility
Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; A1c; glycated hemoglobin; CRP; C-reactive protein; DM; diabetes mellitus; HDL-C; high-density lipoprotein cholesterol; hsCRP; high-sensitivity CRP; ICAM-1; intercellular adhesion molecule 1; IL; interleukin; LDL-C; low-density lipoprotein cholesterol; MCP
Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia
Keywords: مهار کننده فعال کننده پلاسمینوژن 1; Angiotensin converting enzyme; Angiotensinogen; Angiotensin II type 1 receptor; Plasminogen activator inhibitor 1; Vascular dementia